Vincent Rijckborst
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-term outcomes of ruptured hepatocellular carcinoma: international multicentre study.
Journal: The British journal of surgery
Published: March 28, 2023
Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B.
Journal: Journal of viral hepatitis
Published: November 20, 2017
Short article: Management of ruptured hepatocellular carcinoma in a European tertiary care center.
Journal: European journal of gastroenterology & hepatology
Published: April 27, 2016
Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg decline.
Journal: Journal of viral hepatitis
Published: July 21, 2013
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir.
Journal: Antiviral therapy
Published: March 21, 2013
Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders.
Journal: European journal of gastroenterology & hepatology
Published: June 07, 2012
Identification and treatment of chronic hepatitis B in Chinese migrants: results of a project offering on-site testing in Rotterdam, The Netherlands.
Journal: Journal of hepatology
Published: June 03, 2012
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
Journal: Antiviral therapy
Published: January 24, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026